29 studies found for:    " October 04, 2008":" November 03, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Spatial Epidemiology of HIV Infection
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention:
2 Terminated Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
Condition: Human Immunodeficiency Virus
Interventions: Drug: 3-drug anti-HIV therapy;   Drug: Raltegravir
3 Terminated
Has Results
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency Syndrome
Interventions: Drug: Lopinavir 400 mg/ritonavir 100 mg;   Drug: Efavirenz
4 Withdrawn Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients
Conditions: Hepatitis B;   Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: maraviroc;   Drug: etravirine
5 Active, not recruiting HIV Risk Reduction in Youth in the Bahamas
Condition: HIV Infections
Interventions: Behavioral: FOYC;   Behavioral: Goal for it (GFI);   Behavioral: Wonderous Wetlands;   Behavioral: Caribbean Informed Parents and Children Together (CImPACT);   Behavioral: Bahamian Focus on Older Youth (BFOOY);   Behavioral: Health and Family Life Curriculum (HFLE)
6 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
7 Completed Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 1 P inhibitor + 2 nucleoside reverse transcriptase inhibitor or 1 non-nucleoside reverse transcriptase inhibitor + 2 nucleoside reverse transcriptase inhibitor
8 Recruiting Analysis of HIV-1 Replication During Antiretroviral Therapy
Condition: HIV Infection
Intervention:
9 Terminated
Has Results
Aspirin and Antiretroviral Therapy in HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: Aspirin 325mg;   Drug: Antiretroviral therapy (ART)
10 Completed Hepatitis B and HIV Co-Infection in Patients in Uganda
Conditions: Hepatitis B;   HIV Infections
Intervention:
11 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
12 Completed PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection
Condition: HIV Infection
Interventions: Biological: PENNVAX-B;   Biological: GENEVAX IL-12-4532;   Biological: PLACEBO;   Biological: IL-15 adjuvant
13 Recruiting Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV
Condition: HIV Infections
Intervention:
14 Unknown  HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia
Condition: HIV Infections
Intervention:
15 Completed GSK1349572 Drug Interaction Study With Protease Inhibitors
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
16 Unknown  An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
Conditions: HIV Infection;   Tuberculosis
Intervention: Drug: Rifampin
17 Completed A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
Conditions: HIV;   AIDS
Intervention: Drug: Raltegravir (Isentress®)
18 Completed
Has Results
Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
Condition: HIV
Intervention: Drug: Ibalizumab
19 Completed Case Management Alternatives for African American Women at High Risk for HIV
Condition: HIV
Intervention: Behavioral: strengths-based case management
20 Completed ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
Condition: HIV-1
Interventions: Drug: Truvada + Kaletra;   Drug: Kivexa + Kaletra

Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results
Indicates status has not been verified in more than two years